Dr Michael Wong

MD, MPhil, BMedSci
Principal Investigator – Nucleus Network, Brisbane
Translational Researcher in Head & Neck Oncology
Associate Lecturer at The University of Queensland

Dr Michael Wong is a clinician-researcher and Principal Investigator at Nucleus Network, where he leads early-phase clinical trials and drives innovation in clinical research operations. With a background in head and neck oncology, he combines clinical acumen with translational research expertise to advance the development of novel therapeutics.

Dr Wong holds a Doctor of Medicine and a Master of Philosophy from Griffith University, where his research focused on developing tumour organoid models for personalised chemotherapy testing in mucosal head and neck squamous cell carcinoma. He has also contributed to multiple peer-reviewed publications and conference presentations in oncology and ENT.

Clinical Trial Leadership

• Principal Investigator on 14+ Phase 1 trials, including:
  • Self-amplifying mRNA vaccines
  • siRNA therapies
  • Monoclonal antibodies
  • Nanoparticle vaccines
  • Biosimilars
• Former Sub-Investigator on 30+ early-phase trials, with hands-on experience in inpatient and outpatient care, safety monitoring, and protocol implementation.
• Leads AI and technology integration as Innovation Lead, enhancing operational efficiency across Nucleus Network’s global sites.

Academic and Clinical Background

• Associate Lecturer at The University of Queensland, School of Clinical Medicine.
• Former Principal House Officer in Otolaryngology, Head & Neck Surgery at Royal Brisbane and Women’s Hospital and Toowoomba Hospital.
• Experience in Intensive Care Medicine, Plastic Surgery, and Surgical Ward Care.
• Recognised with the Sir Samuel Griffith Scholarship and as a Griffith Honours College Scholar for academic excellence and leadership.

Dr Wong’s work bridges the gap between clinical care, research innovation, and operational excellence, making him a dynamic leader in the future of early-phase clinical trials.